Figure 2
From: Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent
![Figure 2](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1475-2840-6-15/MediaObjects/12933_2007_Article_94_Fig2_HTML.jpg)
Cholesterol and triglyceride analysis of FPLC fractions of serum samples 14 days after viral gene transfer. Western blot analysis for human apoA-I in the HDL fractions is shown below the cholesterol tracing.